REMO HOLANDA DE MENDONÇA FURTADO
WHAT'S NEW IN CARDIOLOGY? - RENATO DELASCIO LOPES
| Artigo | Autor(es) | Referência |
|---|---|---|
| 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026. | Sem autores | Diabetes care. 2026 Jan; 49(Jan):S216-S245. doi: 10.2337/dc26-S010. pii: . |
| 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | , Ndumele Chiadi E, Rodriguez Fatima, Dixon Dave L, Khan Sadiya S, Mukherjee Debabrata, Bajaj Mandeep, Bangalore Sripal, Bozkurt Biykem, Breathett Khadijah, Clarke Shoa L, de Boer Ian H, Ellison David H, Evangelista Lorraine S, Heffron Sean P, Kazi Dhruv S, Kulshreshtha Ambar, Lingvay Ildiko, Low Wang Cecilia C, Mercado Claudia A, Morton John Magaña, Neeland Ian J, Pagidipati Neha, Powell-Wiley Tiffany M, Rangaswami Janani, Rao Goutham, Reza Nosheen, Saeed Anum, St Peter Wendy, Starks J Bradley, Sterling Madeline, Talbot Amy W, Tran Andrew H, Tuttle Katherine R, VanWagner Lisa B, Vest Amanda R, Virani Salim S | Circulation. 2026 Jul; 154(Jul):e50-e158. doi: 10.1161/CIR.0000000000001453. pii: . |
| Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review. | Sebastian Sneha Annie, Padda Inderbir, Johal Gurpreet | Current problems in cardiology. 2024 Feb; 49(Feb):102344. doi: 10.1016/j.cpcardiol.2023.102344. pii: S0146-2806(23)00761-2. |
| Cardiovascular-kidney-metabolic Syndrome: a current and urgent concept. | Abreu Andrea Pio de, Drager Luciano Ferreira, Almeida Madson Queiroz, Bortolotto Luiz Aparecido, Lopes Heno Ferreira | Jornal brasileiro de nefrologia. 2025 ; 47():e20240277. doi: 10.1590/2175-8239-JBN-2024-0277en. pii: e20240277. |
| Cardiovascular-kidney-metabolic syndrome and treatment advances: a narrative review. | Pena Camilo, Flores Jackeline, Nugent Kenneth | Minerva medica. 2025 Jun; 116(Jun):223-233. doi: 10.23736/S0026-4806.25.09607-7. pii: . |
| Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management. | Gunnarsson Sophie, Vito Ortensia, Unwin Robert J | American journal of physiology. Cell physiology. 2026 Jan; 330(Jan):C1-C8. doi: 10.1152/ajpcell.00499.2025. pii: . |
| Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome. | Koufakis Theocharis, Vlahakos Demetrios, Vlachopoulos Charalambos, Kallistratos Emmanouil, Kotsa Kalliopi, Liberopoulos Evangelos N, Stefanidis Ioannis, Hatziagelaki Erifili | American journal of cardiovascular drugs : drugs, devices, and other interventions. 2026 Jan; 26(Jan):11-19. doi: 10.1007/s40256-025-00761-w. pii: . |
| From cardiorenal to cardiorenalmetabolic syndrome: A bibliometric analysis of the top 100 cited articles (2003–2025) | Huatao Zhou, Xiuneng Li, Zilong Zheng, Weijei Tang, Xun Wu and Chengming Fan | Zhou, H., Li, X., Zheng, Z., Tang, W., Wu, X., & Fan, C. (2026). From cardiorenal to cardiorenal-metabolic syndrome: A bibliometric analysis of the top 100 cited articles (2003–2025). Journal of the Renin-Angiotensin-Aldosterone System, 27. https://doi.org/10.1177/14703203261427139 |
| Implementing sodium-glucose co-transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome: a multidisciplinary expert perspective. | Avogaro Angelo, Gori Mauro, Grandaliano Giuseppe, Iacoviello Massimo, Trevisan Roberto | European heart journal. Cardiovascular pharmacotherapy. 2026 May; 12(May):209-221. doi: 10.1093/ehjcvp/pvag020. pii: . |
| Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics. | Anagnostopoulou Lilian, Ktenopoulos Nikolaos, Apostolos Anastasios, Fragoulis Christos, Vlachakis Panayotis, Karakasis Paschalis, Sagris Marios, Milaras Nikias, Drakopoulou Maria, Synetos Andreas, Kyriazis Ioannis, Ioannidis Ioannis, Tsioufis Costas, Toutouzas Konstantinos | Diabetes/metabolism research and reviews. 2026 May; 42(May):e70167. doi: 10.1002/dmrr.70167. pii: e70167. |
| Interventions for the prevention and management of cardiometabolic multiple long-term conditions. | Valabhji Jonathan, Hope David, Sayed Nuha El, Godia Pamela Miloya, Lawson Claire, Seidu Samuel, Khunti Kamlesh | Lancet (London, England). 2026 Jun; 407(Jun):2668-2684. doi: 10.1016/S0140-6736(26)00608-2. pii: S0140-6736(26)00608-2. |
| Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era. | Pohlman Neal, Patel Prem N, Essien Utibe R, Tang Jasmyn J, Joseph Joshua J | The Journal of clinical endocrinology and metabolism. 2025 Jul; 110(Jul):2105-2122. doi: 10.1210/clinem/dgaf295. pii: . |
| SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era. | Grigoriou Konstantinos, Karakasis Paschalis, Nasoufidou Athina, Stachteas Panagiotis, Klisic Aleksandra, Karagiannidis Efstratios, Fyntanidou Barbara, Popovic Djordje S, Patoulias Dimitrios, Antoniadis Antonios P, Fragakis Nikolaos | Medicina (Kaunas, Lithuania). 2025 Oct; 61(Oct):doi: 10.3390/medicina61111903. pii: 1903. |
| Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. | Khan Sadiya S, Bhave Nicole, Blumenthal Roger S, Coresh Josef, Huang Xiaoning, Joseph Joshua J, Khera Amit, Ho Jennifer E, Lloyd-Jones Donald M, Low Wang Cecilia C, Lu Yuan, Morris Pamela B, Nasir Khurram, Natarajan Pradeep, Rangaswami Janani, Rodriguez Fatima, Sperling Laurence S, Virani Salim S, Zhang Sui, Ndumele Chiadi E, , , , , | Circulation. 2026 Jul; 154(Jul):e159-e180. doi: 10.1161/CIR.0000000000001447. pii: . |